News

GlaxoSmithKline plc and iTeos Therapeutics announced an agreement to co-develop and co-commercialise EOS-448, an anti-TIGIT monoclonal antibody currently in phase I development as a…
Read More...

Humanigen, Inc. a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, announced it has initiated a rolling…
Read More...

HiFiBiO Therapeutics, a multinational biotechnology company with unique expertise in immune modulation and drug intelligent science, announced the completion of an oversubscribed $75M…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra…
Read More...

Following careful review and deliberation, the U.S. Food and Drug Administration is taking important steps that will allow a critically needed supply of the Janssen (Johnson &…
Read More...

Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis…
Read More...

Bristol Myers Squibb and Acceleron Pharma Inc. announced the first data from the Phase 2 BEYOND study evaluating Reblozyl(luspatercept-aamt), a first-in-class erythroid maturation…
Read More...

Pfizer Inc. and BioNTech SE announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and…
Read More...

Avantor, Inc. a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced it…
Read More...

Merck, known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with the United States government for molnupiravir (MK-4482).…
Read More...

Arena Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod, a highly selective, once-daily, oral…
Read More...

Know Labs, Inc. an emerging leader in non-invasive medical diagnostics, announced successful results from an independent pre-clinical study validating the company’s Bio-RFID platform…
Read More...

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of oncolytic viruses, announced its partnership with GenScript ProBio,…
Read More...

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on…
Read More...

Scipher Medicine, a precision immunology company matching patients with the most effective therapy, in collaboration with Northeastern University; Brigham and Women’s Hospital, Harvard…
Read More...

Indivior PLC, announced that it is extending its leadership position in substance use disorder ("SUD") treatment by expanding into the under treated cannabis-related disorders,…
Read More...

Icosavax, Inc. announced the first subjects have been dosed with IVX-411, a virus-like particle (VLP) displaying the SARS-CoV-2 receptor-binding domain (RBD), in a Phase 1/2 clinical…
Read More...

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research,…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in…
Read More...

argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced it will regain worldwide rights to its…
Read More...